TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05494320 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study NCT05297643 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05297643 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05415202 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04915248 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05115942 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05387395 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT05163561 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06031584 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05250128 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05137808 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04458116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study NCT04458116 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT04458116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04458116 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04458116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06496581 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05845931 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05667701 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT05716607 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study NCT06674018 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06674018 — Safety Biomarker (SAF): BDNF
Study NCT04758767 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06683222 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06698601 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06703281 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06710132 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06707428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06708767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06708650 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06744400 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06745817 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06744686 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05401409 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05668403 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05527704 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT05166330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04954469 — Predictive Biomarker (PRD): TLR1 mRNA
Genes: TLR1; KIAA0012
Study NCT06433570 — Predictive Biomarker (PRD): KLF1 mRNA
Genes: KLF1; EKLF
Study NCT06459895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06416813 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06243224 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06143553 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06143553 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05570825 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study NCT05579691 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT05267548 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06148233 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT01546012 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04951648 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05805371 — Predictive Biomarker (PRD): PSCA mRNA
Genes: PSCA; UNQ206/PRO232
Study NCT05753527 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05454267 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05906316 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT04706663 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT05262400 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05262400 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06449183 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05232591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05005156 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05005156 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05662397 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05760612 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05760612 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06574165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06574165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06574165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06574165 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT05071781 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT05255653 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05255653 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT05350592 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05421780 — Predictive Biomarker (PRD): BSG mRNA
Genes: BSG; UNQ6505/PRO21383
Study NCT04854265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06581146 — Predictive Biomarker (PRD): MTM1 mRNA
Genes: MTM1; CG2
Study NCT05413499 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04775407 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05942027 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05942027 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06271018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06271018 — Safety Biomarker (SAF): Interleukin 1
Study NCT05783375 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT04730401 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05343013 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04870034 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04987190 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00038259 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00038259 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05674175 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05674175 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06081400 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study NCT05423327 — Predictive Biomarker (PRD): HSD17B13 mRNA
Genes: HSD17B13; SCDR9; SDR16C3; HMFN0376; UNQ497/PRO1014
Study NCT05423327 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT06305247 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study NCT06484556 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05475379 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05646797 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05877599 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05877599 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00000671 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05082831 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03885245 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05360368 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06653023 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05073575 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04961801 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06672731 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06419348 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06746311 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05601505 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04998305 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT06235099 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05437263 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study NCT05437263 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT06205095 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04696055 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05287139 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05287139 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05257720 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05257720 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04972656 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06171750 — Predictive Biomarker (PRD): ANK1 mRNA
Genes: ANK1; ANK
Study NCT05532475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03992469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05672524 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06479876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04005443 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05431582 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCNE1 mRNA
Genes: CCNE1; CCNE
Study NCT05431582 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05252806 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06631079 — Predictive Biomarker (PRD): NEO1 mRNA
Genes: NEO1; IGDCC2; NGN
Study NCT05515549 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06220487 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06686316 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06692036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00002263 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06709560 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06707896 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06490822 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05030623 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05030623 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): VGF mRNA
Genes: VGF
Study NCT06710015 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06710015 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05725369 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study NCT04691323 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06709092 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study NCT05653193 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06710951 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06710951 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06710301 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05324345 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06707259 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04652063 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT06190210 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05420519 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT06160752 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05217784 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06744933 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06744933 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05120648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06528873 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT06528873 — Safety Biomarker (SAF): Cytochrome c
Study NCT04837092 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT05889130 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06005974 — Predictive Biomarker (PRD): AXIN1 mRNA
Genes: AXIN1; AXIN
Study NCT06005974 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT06475118 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06252298 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06023901 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06023901 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT04522180 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study NCT04522180 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05725798 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04750941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04750941 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04750941 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05102695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05102695 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05447377 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06363357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05008445 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05401435 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05779553 — Predictive Biomarker (PRD): CD248 mRNA
Genes: CD248; CD164L1; TEM1
Study NCT05779553 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04834778 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT04952584 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04571216 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT04935879 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06513364 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05780710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06692452 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06746701 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06747234 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06747234 — Predictive Biomarker (PRD): FFAR2 mRNA
Genes: FFAR2; FFA2; GPCR43; GPR43
Study NCT06747234 — Predictive Biomarker (PRD): HCAR2 mRNA
Genes: HCAR2; GPR109A; HCA2; HM74A; NIACR1
Study NCT04895852 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05903716 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT06000423 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT05238896 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04742153 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04955145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04955145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05693727 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT05693727 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05693727 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05017805 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06173141 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04968210 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05188755 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06488573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05748444 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05748444 — Safety Biomarker (SAF): Interleukin 1
Study NCT05748444 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05792137 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06405958 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06218342 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04923932 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06325137 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06325137 — Predictive Biomarker (PRD): Long noncoding RNA GAS5
Study NCT05249387 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT04738331 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05923905 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05945394 — Predictive Biomarker (PRD): TRAF3IP2 mRNA
Genes: TRAF3IP2; C6orf2; C6orf4; C6orf5; C6orf6
Study NCT04933006 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06315426 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06315426 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT06478173 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06021665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06021665 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05730140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05268107 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT05268107 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT05065190 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05639933 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05639933 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04529044 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT04794699 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT06193902 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05998408 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05755191 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05065879 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04768725 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04768725 — Safety Biomarker (SAF): BDNF
Study NCT04983940 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03928275 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00001122 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06573073 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05273905 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05910814 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05910814 — Safety Biomarker (SAF): BDNF
Study NCT06283433 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05146960 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05287984 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06484036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06294236 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04988425 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06347133 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT06347133 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00000849 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04938479 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05020678 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05633693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05556382 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT05293132 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05624554 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53